VANGL1 and urinary bladder carcinoma: In the present study, we observed that miR-145-5p inhibitor could partially reverse the effects of circ_VANGL1 deletion on cell viability, apoptosis, and the resistance to doxorubicin, suggesting a regulatory network of circ_VANGL1/miR-145-5p in bladder cancer progression.